Amniocentesis Needle Market worth 172.8 Million USD by 2022
According to the new market research report "Amniocentesis Needle Market by Type
(Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), Procedure
(Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion), End
User (Hospitals, Diagnostic Centers, Clinics) - Global Forecast to 2022", published
by MarketsandMarkets™, analyzes and studies the major market
drivers, restraints/challenges, and opportunities in North America, Europe,
Asia-Pacific, and the Rest of the world (RoW).
Don’t miss out on business opportunities in Amniocentesis Needle Market.
Speak to our analyst and gain crucial industry
insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=18541768
The amniocentesis needles
market is expected to reach USD 172.8 million by 2022 from USD 146.4 million in
2016 at a CAGR of 2.8%.
The base year for this study is 2016 and the forecast
period is 2017–2022. 100–150 mm needles are the most commonly used
amniocentesis needles and are expected to account for the largest share of the
global market in 2017. The large share of this segment can be attributed to the
fact that these needles are suitable for most patients on account of their
optimal length.Use of amniocentesis needles in amniocentesis procedures drives the global 100–150 mm needles market
This type of needle is suitable for use in females with a normal body-mass index (BMI) of 18.50–24.99 kg/m2. There is an increase in the proportion of women who are overweight, this proportion will still be lesser than the proportion of women with normal BMI. This is one of the major factors responsible for the large share of 100–150 mm needles in the amniocentesis needles market. Amniocentesis procedure is the most commonly recommended invasive prenatal diagnostic test to detect chromosomal disorders, infections, or birth defects. In spite of a small proportion of risks associated with this procedure, amniocentesis is carried out to diagnose the abnormalities in the developing fetus. These are the major factors responsible for the large share of this procedure segment in the amniocentesis needles market.
 |
Amniocentesis Needle Market
74 – Tables
34 - Figures
132 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/amniocentesis-needle-market-18541768.html
The following are the major objectives of the study:
- To
define, describe, segment, and forecast the amniocentesis needles market
on the basis of type, procedure, end user, and region
- To
forecast revenue of the market segments with respect to four main regional
segments, namely, North America, Europe, Asia, and the Rest of the World
(RoW)
- To
identify the micromarkets with respect to drivers, restraints,
industry-specific challenges, opportunities, and trends affecting the
growth of the market
- To
strategically analyze market segments and subsegments with respect to
individual growth trends, prospects, and contributions to the overall
market
- To
analyze opportunities in the market for stakeholders and provide details
of the competitive landscape for market leaders
- To
profile the key players and comprehensively analyze their market position
and core competencies in terms of market developments and growth
strategies
- To
track and analyze competitive developments such as partnerships,
agreements, collaborations, and joint ventures; mergers and acquisitions;
product launches; and research and development activities in the
amniocentesis needles market
Request
for Free Sample Report @
Target
Audience for this Report:
- · Manufacturers and vendors of amniocentesis needles
- · Hospitals
- · Diagnostic centers
- · Private clinics
- · Research associations related to amniocentesis needles
- · Various research and consulting firms
- · Distributors of amniocentesis needles
- · Contract research manufacturers of amniocentesis needles
- · Research institutes
- · Government bodies
- · Amniocentesis needles database and software providers
- · Venture capitalists
About MarketsandMarkets™
MarketsandMarkets™
provides quantified B2B research on 30,000 high growth niche opportunities/threats
which will impact 70% to 80% of worldwide companies’ revenues. Currently
servicing 7500 customers worldwide including 80% of global Fortune 1000
companies as clients. Almost 75,000 top officers across eight industries
worldwide approach MarketsandMarkets™ for their painpoints around revenues
decisions.
Our 850 fulltime
analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets
following the "Growth Engagement Model – GEM". The GEM aims at
proactive collaboration with the clients to identify new opportunities,
identify most important customers, write "Attack, avoid and defend"
strategies, identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this
year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s
flagship competitive intelligence and market research platform, "Knowledge
Store" connects over 200,000 markets and entire value chains for deeper
understanding of the unmet insights along with market sizing and forecasts of
niche markets.
Contact Us:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
Comments
Post a Comment
If you have any issue, Let me know ?